DK0754058T3 - Sårheling - Google Patents

Sårheling

Info

Publication number
DK0754058T3
DK0754058T3 DK95913237T DK95913237T DK0754058T3 DK 0754058 T3 DK0754058 T3 DK 0754058T3 DK 95913237 T DK95913237 T DK 95913237T DK 95913237 T DK95913237 T DK 95913237T DK 0754058 T3 DK0754058 T3 DK 0754058T3
Authority
DK
Denmark
Prior art keywords
wound healing
beta
growth factor
agent
tgf
Prior art date
Application number
DK95913237T
Other languages
English (en)
Inventor
Mark W J Ferguson
Mamta Shah
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9406154A external-priority patent/GB2288118A/en
Priority claimed from GBGB9424898.6A external-priority patent/GB9424898D0/en
Application filed by Univ Manchester filed Critical Univ Manchester
Application granted granted Critical
Publication of DK0754058T3 publication Critical patent/DK0754058T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DK95913237T 1994-03-29 1995-03-29 Sårheling DK0754058T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9406154A GB2288118A (en) 1994-03-29 1994-03-29 Wound healing composition
GBGB9424898.6A GB9424898D0 (en) 1994-12-09 1994-12-09 Wound healing
PCT/GB1995/000704 WO1995026203A1 (en) 1994-03-29 1995-03-29 Wound healing

Publications (1)

Publication Number Publication Date
DK0754058T3 true DK0754058T3 (da) 2000-02-07

Family

ID=26304595

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99201184T DK0968723T3 (da) 1994-03-29 1995-03-29 Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor
DK95913237T DK0754058T3 (da) 1994-03-29 1995-03-29 Sårheling

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK99201184T DK0968723T3 (da) 1994-03-29 1995-03-29 Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor

Country Status (12)

Country Link
US (1) US5972335A (da)
EP (2) EP0968723B1 (da)
JP (1) JP4083794B2 (da)
AT (2) ATE435030T1 (da)
AU (1) AU710153B2 (da)
CA (1) CA2186269C (da)
DE (2) DE69513158T2 (da)
DK (2) DK0968723T3 (da)
ES (2) ES2329531T3 (da)
GR (1) GR3032266T3 (da)
NZ (1) NZ282856A (da)
WO (1) WO1995026203A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
GB9601081D0 (en) * 1995-10-06 1996-03-20 Cambridge Antibody Tech Specific binding members for human transforming growth factor beta;materials and methods
GB2306481A (en) 1995-10-21 1997-05-07 Univ Manchester Pharmaceutical comprising a stimulator of activin and/or inhibin
GB9702943D0 (en) 1997-02-13 1997-04-02 Univ Manchester Wound healing
DE10022074A1 (de) * 2000-05-06 2001-11-08 Henkel Kgaa Elektrochemisch erzeugte Schichten zum Korrosionsschutz oder als Haftgrund
US6509318B1 (en) 2000-09-29 2003-01-21 The Regents Of The University Of California TGF-B inhibitors and methods
US7452454B2 (en) * 2001-10-02 2008-11-18 Henkel Kgaa Anodized coating over aluminum and aluminum alloy coated substrates
US7569132B2 (en) * 2001-10-02 2009-08-04 Henkel Kgaa Process for anodically coating an aluminum substrate with ceramic oxides prior to polytetrafluoroethylene or silicone coating
GB0217136D0 (en) * 2002-07-24 2002-09-04 Renovo Ltd Wound healing & treatment of fibrosis
US20050074453A1 (en) * 2003-10-02 2005-04-07 Ferree Bret A. Methods of preventing adhesions following laminectomies and other surgical procedures
AU2005230848B9 (en) * 2004-03-31 2011-06-02 Genentech, Inc. Humanized anti-TGF-beta antibodies
EP2498798A4 (en) * 2009-11-10 2014-01-01 Univ Columbia COMPOSITIONS AND METHODS OF WOUND TREATMENT
AU2011222540B2 (en) * 2010-03-05 2016-09-29 Wake Forest University Health Sciences Controlled delivery system
EP2744480B8 (en) 2011-08-17 2019-06-26 Keratin Biosciences, Inc. Low protein percentage gelling compositions
WO2013025928A2 (en) 2011-08-17 2013-02-21 Keranetics Llc Methods for extracting keratin proteins
CA3023553A1 (en) * 2012-11-06 2014-05-15 Scholar Rock, Inc. Compositions and methods for modulating cell signaling
US9827245B2 (en) 2013-03-15 2017-11-28 KeraNetics, LLC Keratin compositions comprising halofuginone
LT2981822T (lt) 2013-05-06 2020-12-28 Scholar Rock, Inc. Kompozicijos ir būdai, skirti augimo faktoriaus moduliacijai
MX2018014047A (es) 2016-05-17 2019-06-20 Genentech Inc Firmas de genes estromales para el diagnóstico y uso en inmunoterapia.
EP3707510B1 (en) 2017-11-06 2024-06-26 F. Hoffmann-La Roche AG Diagnostic and therapeutic methods for cancer
WO2023080900A1 (en) 2021-11-05 2023-05-11 Genentech, Inc. Methods and compositions for classifying and treating kidney cancer
WO2024077166A1 (en) 2022-10-05 2024-04-11 Genentech, Inc. Methods and compositions for classifying and treating lung cancer
WO2024077095A1 (en) 2022-10-05 2024-04-11 Genentech, Inc. Methods and compositions for classifying and treating bladder cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01502669A (ja) * 1987-03-13 1989-09-14 アムジエン・インコーポレーテツド 精製された血小板由来の成長因子及びその精製方法
US5094941A (en) * 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
CA2065860C (en) * 1989-09-29 2001-03-27 Wayne A. Border Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
DE69228700T2 (de) * 1991-12-04 1999-09-09 Jolla Cancer Res Found Verwendung von Decorin oder Biglycan zur Herstellung eines Medikaments für die Behandlung von Diabetes-bedingter Zustände
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
AU3943793A (en) * 1992-04-01 1993-11-08 Whittier Institute For Diabetes And Endocrinology, The Methods of inhibiting or enhancing scar formation in the CNS
GB9217206D0 (en) 1992-08-13 1992-09-23 Pointer John C Photo labels
AU5587094A (en) * 1992-10-26 1994-05-24 Kirin Brewery Company, Limited Method for producing large latent transforming growth factor-beta complexes and large latency associated peptide
JP4350370B2 (ja) * 2002-12-27 2009-10-21 株式会社半導体エネルギー研究所 電子回路及び電子機器

Also Published As

Publication number Publication date
JP4083794B2 (ja) 2008-04-30
GR3032266T3 (en) 2000-04-27
EP0754058B1 (en) 1999-11-03
WO1995026203A1 (en) 1995-10-05
DE69513158D1 (de) 1999-12-09
EP0754058A1 (en) 1997-01-22
DE69535976D1 (de) 2009-08-13
AU2077895A (en) 1995-10-17
DK0968723T3 (da) 2009-11-09
JPH09510967A (ja) 1997-11-04
CA2186269C (en) 2008-06-03
ATE186220T1 (de) 1999-11-15
EP0968723A1 (en) 2000-01-05
ES2140670T3 (es) 2000-03-01
NZ282856A (en) 1998-06-26
CA2186269A1 (en) 1995-10-05
AU710153B2 (en) 1999-09-16
ES2329531T3 (es) 2009-11-26
DE69513158T2 (de) 2000-05-04
ATE435030T1 (de) 2009-07-15
EP0968723B1 (en) 2009-07-01
US5972335A (en) 1999-10-26

Similar Documents

Publication Publication Date Title
DK0754058T3 (da) Sårheling
ATE241334T1 (de) Mittel zur förderung des haarwachstums
ATE247483T1 (de) Matrixprotein enthaltende zusammensetzungen für entzündliche und infektiöse zustände
DE69524682D1 (de) Mittel zur Behandlung von Wunden
FI953180A0 (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
CY1108110T1 (el) Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου
EP0506658A4 (en) Compositions and method for treating painful, inflammatory or allergic disorders
ATE235245T1 (de) Pharmaceutische komposition
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
DE69104656D1 (de) Heilende Zusammensetzung zur örtlichen Anwendung.
WO2001030334A3 (en) 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation
MX9204338A (es) Metodos de tratamiento con antimicrobianos y composiciones antimicrobianas.
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь